솔루트 캐리어 패밀리 22 멤버 8 또는유기 음이온 트랜스포터 3(OAT3)은 인간에서 SLC22A8유전자에 의해 인코딩되는 단백질이다.[5][6][7]
함수
OAT3는 유기 이온의 운반과 배설에 관여하는데, 그 중 일부는 약물(예: 페니실린 G(벤지엘피닐린), 메토트렉산염(MTX), 인도메타신(NSAID), 시프로플로크사신(플루오로퀴놀론 항생제)이며, 일부는 순수한 독성물질이다.[6]SLC22A8(OAT3)은 체토솔에 디카르복실산염 재진입하는 원동력인 내부 나트륨 경사로에 간접적으로 의존한다.세포 내에서 생성되거나 세포외 공간에서 재활용된 알파-케토글루타레이트 같은 디카르복실레이트는 그들의 농도 경사에 대항하여 유기 음이온의 유입을 부채질하는 교환 기판으로 사용된다.인코딩된 단백질은 일체형 막 단백질이며 신장 근위부 관상세포의 근측막으로 국부화 되어 있는 것으로 보인다.[7]
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Race JE, Grassl SM, Williams WJ, Holtzman EJ (1999). "Molecular Cloning and Characterization of Two Novel Human Renal Organic Anion Transporters (hOAT1 and hOAT3)". Biochemical and Biophysical Research Communications. 255 (2): 508–14. doi:10.1006/bbrc.1998.9978. PMID10049739.
Nishizato Y, Ieiri I, Suzuki H, Kimura M, Kawabata K, Hirota T, Takane H, Irie S, et al. (2003). "Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics". Clinical Pharmacology & Therapeutics. 73 (6): 554–65. doi:10.1016/S0009-9236(03)00060-2. PMID12811365. S2CID6570648.
Bakhiya A, Bahn A, Burckhardt G, Wolff N (2003). "Human Organic Anion Transporter 3 (hOAT3) can Operate as an Exchanger and Mediate Secretory Urate Flux". Cellular Physiology and Biochemistry. 13 (5): 249–56. doi:10.1159/000074539. PMID14586168. S2CID24494954.
Sakurai Y, Motohashi H, Ueo H, Masuda S, Saito H, Okuda M, Mori N, Matsuura M, et al. (2004). "Expression Levels of Renal Organic Anion Transporters (OATs) and Their Correlation with Anionic Drug Excretion in Patients with Renal Diseases". Pharmaceutical Research. 21 (1): 61–7. doi:10.1023/B:PHAM.0000012153.71993.cb. hdl:2433/144752. PMID14984259. S2CID28592120.
Srimaroeng C, Chatsudthipong V, Aslamkhan AG, Pritchard JB (2004). "Transport of the Natural Sweetener Stevioside and Its Aglycone Steviol by Human Organic Anion Transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8)". Journal of Pharmacology and Experimental Therapeutics. 313 (2): 621–8. doi:10.1124/jpet.104.080366. PMID15644426. S2CID15017941.
Tahara H, Shono M, Kusuhara H, Kinoshita H, Fuse E, Takadate A, Otagiri M, Sugiyama Y (2005). "Molecular Cloning and Functional Analyses of OAT1 and OAT3 from Cynomolgus Monkey Kidney". Pharmaceutical Research. 22 (4): 647–60. doi:10.1007/s11095-005-2503-0. PMID15846473. S2CID26613337.
Mizuno N, Takahashi T, Iwase Y, Kusuhara H, Niwa T, Sugiyama Y (2007). "Human Organic Anion Transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) Transport Edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and Its Sulfate Conjugate". Drug Metabolism and Disposition. 35 (8): 1429–34. doi:10.1124/dmd.106.013912. PMID17502342. S2CID13006597.
Matsumoto S, Yoshida K, Ishiguro N, Maeda T, Tamai I (2007). "Involvement of Rat and Human Organic Anion Transporter 3 in the Renal Tubular Secretion of Topotecan [(S)-9-Dimethylaminomethyl-10-hydroxy-camptothecin hydrochloride]". Journal of Pharmacology and Experimental Therapeutics. 322 (3): 1246–52. doi:10.1124/jpet.107.123323. PMID17556638. S2CID43487664.
Nozaki Y, Kusuhara H, Kondo T, Iwaki M, Shiroyanagi Y, Nakayama H, Horita S, Nakazawa H, et al. (2007). "Species Difference in the Inhibitory Effect of Nonsteroidal Anti-Inflammatory Drugs on the Uptake of Methotrexate by Human Kidney Slices". Journal of Pharmacology and Experimental Therapeutics. 322 (3): 1162–70. doi:10.1124/jpet.107.121491. PMID17578901. S2CID20950205.
Windass AS, Lowes S, Wang Y, Brown CD (2007). "The Contribution of Organic Anion Transporters OAT1 and OAT3 to the Renal Uptake of Rosuvastatin". Journal of Pharmacology and Experimental Therapeutics. 322 (3): 1221–7. doi:10.1124/jpet.107.125831. PMID17585018. S2CID24479885.